Icon Wealth Partners’s AstraZeneca AZN Stock Holding History

Icon Wealth Partners’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$142K	Buy	+1,049	New	+$143K	0.02%	329
2020 Q3	–	Sell	-2,320	Closed	-$245K	–	256
2020 Q2	$245K	Buy	+2,320	New	+$240K	0.06%	217
2020 Q1	–	Sell	-2,037	Closed	-$203K	–	158
2019 Q4	$203K	Sell	2,037 -305	-13%	-$28.7K	0.06%	166
2019 Q3	$209K	Sell	2,342 -153	-6%	-$13.3K	0.07%	151
2019 Q2	$206K	Buy	2,495 +140	+6%	+$11K	0.07%	151
2019 Q1	$190K	Sell	2,355 -1,937	-45%	-$153K	0.07%	158
2018 Q4	$326K	Sell	4,292 -1,288	-23%	-$101K	0.16%	94
2018 Q3	$442K	Sell	5,580 -1,155	-17%	-$87.4K	0.18%	89
2018 Q2	$473K	Sell	6,735 -851	-11%	-$61.2K	0.2%	80
2018 Q1	$531K	Sell	7,586 -924	-11%	-$64K	0.28%	79
2017 Q4	$591K	Buy	+8,510	New	+$574K	0.29%	74

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Icon Wealth Partners's AZN Position: Q3 2023 in Review

Icon Wealth Partners opened a new position in AstraZeneca (AZN) in Q3 2023: 1,049 shares worth $142K. The stake represents 0.02% of the portfolio and ranks #329 among its holdings. This is a return to the name: Icon Wealth Partners previously reported a position in AZN as recently as Q2 2020.

Icon Wealth Partners first reported a position in AZN in Q4 2017 and has held it in 11 quarters since. The position peaked at $591K in Q4 2017. 1,074 funds tracked by Wall St. Rank hold AZN as of Q3 2023.

Icon Wealth Partners held 1,049 shares of AstraZeneca worth $142K as of Q3 2023.
AstraZeneca was a new Icon Wealth Partners position in Q3 2023.
AstraZeneca made up 0.02% of Icon Wealth Partners's portfolio in Q3 2023, its #329 holding.
Icon Wealth Partners first reported a position in AstraZeneca in Q4 2017 and has held it in 11 quarters since.
Icon Wealth Partners's AstraZeneca position peaked at $591K in Q4 2017.
1,074 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2023.

Based on Icon Wealth Partners's 13F filing for Q3 2023, filed 14 Nov 2023.